![Robert Karr](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert Karr
Director Ejecutivo en Drosmed LLC .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Sangtae Kim | M | - | 6 años | |
Andrew T. Hoyne | M | - |
Drosmed LLC
![]() Drosmed LLC Drugstore ChainsRetail Trade Drosmed LLC provides and develops drugs. It utilizes the fruit fly drosophila to take a whole animal approach to drug discovery for cancer metastasis and for diabetes-related diseases. The company was founded by Thomas John Baranski and Ross L. Cagan in 2006 and is headquartered in St. Louis, MO. | - |
Thomas John Baranski | M | - |
Drosmed LLC
![]() Drosmed LLC Drugstore ChainsRetail Trade Drosmed LLC provides and develops drugs. It utilizes the fruit fly drosophila to take a whole animal approach to drug discovery for cancer metastasis and for diabetes-related diseases. The company was founded by Thomas John Baranski and Ross L. Cagan in 2006 and is headquartered in St. Louis, MO. | 18 años |
Ross L. Cagan | M | - |
Drosmed LLC
![]() Drosmed LLC Drugstore ChainsRetail Trade Drosmed LLC provides and develops drugs. It utilizes the fruit fly drosophila to take a whole animal approach to drug discovery for cancer metastasis and for diabetes-related diseases. The company was founded by Thomas John Baranski and Ross L. Cagan in 2006 and is headquartered in St. Louis, MO. | 18 años |
Eric Gulve | M | - |
Drosmed LLC
![]() Drosmed LLC Drugstore ChainsRetail Trade Drosmed LLC provides and develops drugs. It utilizes the fruit fly drosophila to take a whole animal approach to drug discovery for cancer metastasis and for diabetes-related diseases. The company was founded by Thomas John Baranski and Ross L. Cagan in 2006 and is headquartered in St. Louis, MO. | - |
Suneet Varma | M | 55 | 23 años | |
Mike McDermott | M | 58 | 21 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Louis J. Arcudi | M | 63 |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | 11 años |
Jeffrey Kindler | M | 68 | 8 años | |
James B. Wyngaarden | M | 99 |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | 23 años |
Vin Milano Milano | M | 60 |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | - |
Richard de Schutter | M | 83 |
G.D. Searle & Co., Inc.
![]() G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | 4 años |
James Geraghty | M | 69 |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | - |
George A. Lorch | M | 82 | 15 años | |
Jill Conwell | F | - |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | - |
Everett Cunningham | M | 57 | 9 años | |
Mark Goldberg | M | 69 |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | 8 años |
Julian Baker | M | 57 |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | 4 años |
Abdul-Wahab Umari | M | - |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | 2 años |
Alice S. Bexon | M | 54 |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | - |
Kelvin Neu | M | 50 |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | 5 años |
Barrington John Albert Furr | M | 80 |
GTx, Inc.
![]() GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | 4 años |
Jason Shackelford | M | 48 |
GTx, Inc.
![]() GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | - |
Michael Carter | M | 86 |
GTx, Inc.
![]() GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | - |
Yi Ning Zhao | M | 53 | 8 años | |
George Milne | M | 80 | 32 años | |
Alexandra Kropotova | M | 51 | 5 años | |
Robert A. Doody | M | - |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | - |
Paul Fitzhenry | M | 64 | 4 años | |
Michael R. Jirousek | M | 65 | 5 años | |
William Herbert Gray | M | 82 | 13 años | |
Kenneth Robinson | M | 69 |
GTx, Inc.
![]() GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | - |
C. Hartley | M | 81 |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | 17 años |
Jeffrey G. Hesselberg | M | 65 |
GTx, Inc.
![]() GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | - |
Eve Elizabeth Slater | M | 78 |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | 6 años |
Malcolm MacCoss | M | 76 |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | 5 años |
Michael Bruce | M | - | 12 años | |
Paul M. Villani | M | 58 | 6 años | |
Yugal Kishor C. Sikri | M | 66 | 6 años | |
Lee Golden | M | 56 | 4 años | |
John F. Niblack | M | 85 | 35 años | |
Paul E. Kirincic | M | 73 | 3 años | |
Edmund Harrigan | M | 71 | 12 años | |
Viviane Monges | F | 60 | 5 años | |
John W. Poyhonen | M | 64 | 7 años | |
Mariano García-Valiño | M | 58 | 8 años | |
James L. Freddo | M | 69 | 3 años | |
Joseph Monahan | M | 69 | 7 años | |
Joann Eisenhart | M | 65 | 12 años | |
Jeffrey Kent | M | 62 | 4 años | |
Feng Guo | M | 54 | 11 años | |
Mark J. Taisey | M | - | 5 años | |
Christopher Verni | M | 49 | 3 años | |
Michelle Nasir | F | - | 6 años | |
Tod Smeal | M | 59 | 12 años | |
Tanya de Foras | F | 53 | 10 años | |
Adrian Otte | M | - | 6 años | |
Muriel Cottard | M | - | 4 años | |
Margaret Marshall | M | 67 | 8 años | |
John Chapman | M | 70 | 4 años | |
Deborah Baron | F | 55 | - | |
Yvonne R. Jackson | F | 74 | 3 años | |
David Dickason | M | - |
GTx, Inc.
![]() GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | 4 años |
Spiros Liras | M | - | 4 años | |
Bruce Curtis Crosby | M | - | 2 años | |
Rajmund Ireneusz Martyniuk | M | 62 | 4 años | |
David J. Wustrow | M | 65 | 2 años | |
Krishan K. Arora | M | 83 | 5 años | |
Craig M. Audet | M | 59 | 5 años | |
Frank Sciavolino | M | 83 | 35 años | |
Wendell Wierenga | M | 76 | 10 años | |
Pat Parr | M | - | 6 años | |
Brian R. Krause | M | - | - | |
Claus Egstrand | M | 63 | 3 años | |
Kristin Peck | F | 52 | 8 años | |
William Sigmund | M | - | 4 años | |
Linda Armstrong | M | 61 | 6 años | |
Richard D. Fulmer | M | 78 | 24 años | |
Lance Berman | M | 53 | 6 años | |
Mark W. Pierce | M | 75 | 3 años | |
Warren R. Winter | M | - | 15 años | |
Robert E. Grasty | M | 55 | - | |
Mary R. Flack | M | - | 7 años | |
Bonne Adams | F | 47 | 2 años | |
Anja Guntermann | M | - | 9 años | |
Navin Jacob | M | - | 3 años | |
Julie A. Olson | M | - | 19 años | |
Arthur Peter Bertolino | M | 69 | 4 años | |
Tim Bertram | M | 68 | 5 años | |
Peter Powchik | M | 67 | 5 años | |
Lauren Silverman | M | 69 | 5 años | |
Nicholas Lee Gurreri | M | - | 4 años | |
Thomas G. Gant | M | - | 6 años | |
Francesco Granata | M | 73 | 2 años | |
Rom Eliaz | M | 52 | 2 años | |
Daniela Oniciu | M | - | 4 años | |
Dan Garofalo | M | 48 | 4 años | |
William R. Howell | M | 88 | 9 años | |
Ali Seyedroudbari | M | - | - | |
Seth Brodsky | M | - | 3 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 100 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Robert Karr
- Red Personal